| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/06/2008 | US20080274201 Coating microcapsule with a photoinitiator, placingin an aqueous macromer solution, exposing to light radiation, polymerization; forming a microcapsule containing at least one cell; macromers are polymerized using a photoinitiator dye; suspension or interfacial polymerization |
| 11/06/2008 | US20080274200 Dose titratable liquid dosage forms of acid labile drugs |
| 11/06/2008 | US20080274199 Monodisperse particles having homogeneously dispersed active material; biocompatible, biodegradable |
| 11/06/2008 | US20080274198 Alternating layers of high and low refactive index metal oxides; appealing multicolor appearance; light and moisture protection; shelf life |
| 11/06/2008 | US20080274197 Lyophilized formulation |
| 11/06/2008 | US20080274196 Bioequivalent to tablet dosage form; combination of compacted and plain powder; controlled particle size; bioavailability without enhancing substances |
| 11/06/2008 | US20080274195 Compositions and Methods for Making and Using Nanoemulsions |
| 11/06/2008 | US20080274194 Stabilized Hme Composition With Small Drug Particles |
| 11/06/2008 | US20080274193 Retinoic Acid-Containing Antidiabetic Agent |
| 11/06/2008 | US20080274192 Pharmaceutical Compositions Comprising an Amorphous Form of a Vegf-R-Inhibitor |
| 11/06/2008 | US20080274191 Bioadhesive Composition With Programmed Release |
| 11/06/2008 | US20080274190 Comprising a poly(ethylene glycol)-based compound, or a copolymer of the poly(ethylene glycol)-based compound and a biodegradable polymer; and a polyurethane-based oligomer |
| 11/06/2008 | US20080274189 Organic Compounds Comprising a Glycopyrr Onium Salt |
| 11/06/2008 | US20080274188 Oral Vehicle For Systemic Pharmaceuticals |
| 11/06/2008 | US20080274187 Hard capsule composition and method of use |
| 11/06/2008 | US20080274186 NELL-1 enhanced bone mineralization |
| 11/06/2008 | US20080274185 Inducing angiogenesis enhancing implant success of adult mesenchymal cell scaffolds |
| 11/06/2008 | US20080274184 Extracellular matrix (ECM) combined with therapeutic agents; promoting tissue wound healing; reducing side effects |
| 11/06/2008 | US20080274183 Melt extrudable, polymeric fiber suitable for controlled, sustained internal administration; blend of cellulose alkyl ester and secondary biocompatible polymer |
| 11/06/2008 | US20080274182 Rapid, low energy drying without loss of protective and/or swallowing properties; enzymatic molecular weight reduction; minimizing solvent requirements |
| 11/06/2008 | US20080274181 Bupropion hydrobromide and therapeutic applications |
| 11/06/2008 | US20080274180 Low cost, simple production; tablets; increased stomach retention time; contains gas generator, release retardant, disintegrant, hydrophilic stabilizers and release modifier; unique flexibility and rigidity properties preventing expulsion through pyloric sphincter |
| 11/06/2008 | US20080274178 Compression molded active ingredient, crystalline cellulose, inorganic excipient, carmellose and lubricant; hardness; pleasant ingestion feeling; simple preparation |
| 11/06/2008 | US20080274177 Monolithic coating comprising aqueous dispersion of neutral acrylic ester copolymer without any functional groups and polyglycol; short curing times; shelf life |
| 11/06/2008 | US20080274176 Pharmaceutical Lipid Compositions |
| 11/06/2008 | US20080274175 Compositions Comprising Edible Oils and Vitamins and/or Minerals and Methods for Making the Compositions |
| 11/06/2008 | US20080274174 Stable pancreatic enzyme compositions |
| 11/06/2008 | US20080274173 Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents |
| 11/06/2008 | US20080274172 Liposome Preparation Method |
| 11/06/2008 | US20080274171 Renin Inhibitors Nitroderivatives |
| 11/06/2008 | US20080274170 Peptide epitopes of apolipoprotein b |
| 11/06/2008 | US20080274169 Flexible, penetrating liposomal carrier system; bilayer of phospholipids, a hydrophobic photosensitizer, skin penetration enhancers; penetrating through an intact stratum corneum or wound surface without removal of photosensitizer from bilayer without agglomeration of bilayers |
| 11/06/2008 | US20080274168 Transdermal delivery device disposal system |
| 11/06/2008 | US20080274167 Impermeable backing layer, an active substance layer of sufentanyl and a polymer mixture with microreservoirs dispersed, an active substance dissolved in the microreservoirs |
| 11/06/2008 | US20080274166 Patch for Transdermal Drug Delivery |
| 11/06/2008 | US20080274165 Wound healing compositions containing keratin biomaterials |
| 11/06/2008 | US20080274164 Atrium Patch |
| 11/06/2008 | US20080274163 Nose and throat anti-influenza solution and method of use |
| 11/06/2008 | US20080274162 Composition of Lactobacillus bacteria and a carrier; rectal delivery providesoptimum method of transmission of the treatment |
| 11/06/2008 | US20080274161 Hydrogels and hydrogel particles |
| 11/06/2008 | US20080274153 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 11/06/2008 | US20080274152 Having large particle size color travel pigments; retaining the color travel effect upon application to skin |
| 11/06/2008 | US20080274149 Encapsulation and Controlled Release of Biologically Active Ingredients with Enzymatically Degradable Microparticulate, Hyperbranched Polymers |
| 11/06/2008 | US20080274146 film-form application strip, which is in each case bonded detachably to an active ingredient-containing plaster and a separate active ingredient release regulator |
| 11/06/2008 | US20080274129 Hla-A2 Tumor Associated Antigen Peptides and Compositions |
| 11/06/2008 | US20080274097 Using ultrasonic vibration at treatment sites to enhance efficacy of therapeutic treatment |
| 11/06/2008 | US20080274081 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 11/06/2008 | US20080274061 Method for Treating a Restless Limb Disorder |
| 11/06/2008 | US20080274060 Therapeutic Foam |
| 11/06/2008 | US20080274056 Nanoparticle delivery systems for membrane-integrating peptides |
| 11/06/2008 | US20080274044 aqueous dispersion comprising insoluble therapeutic or diagnostic agent particles having a surface modifier; treating a respiratory illness |
| 11/06/2008 | DE4232465B4 Arzneimittel oder diätetische Lebensmittel, ihre Verwendung und Verfahren zu deren Herstellung Drug or dietary foods, their use and processes for their preparation |
| 11/06/2008 | DE202008011931U1 Mehrsegmenttablette Multi-segment tablet |
| 11/06/2008 | DE102007020578A1 Wässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole Aqueous aerosol preparations containing therapeutically effective microorganisms or parts of microorganisms and methods for producing corresponding aerosols |
| 11/06/2008 | CA2688624A1 Biocidic medical devices, implants and wound dressings |
| 11/06/2008 | CA2685593A1 Combination pharmaceutical compositions |
| 11/06/2008 | CA2685591A1 Pharmaceutical nimodipine compositions |
| 11/06/2008 | CA2685467A1 Membrane shell of an implantable dosage system |
| 11/06/2008 | CA2685362A1 Compositions and methods for transmucosal delivery of domperidone |
| 11/06/2008 | CA2685264A1 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
| 11/06/2008 | CA2685261A1 Pharmaceutical excipient complex |
| 11/06/2008 | CA2685184A1 Solid dosage forms |
| 11/06/2008 | CA2685131A1 Stable solid preparation containing 4,5-epoxymorphinan derivative |
| 11/06/2008 | CA2684977A1 A method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant |
| 11/06/2008 | CA2683068A1 Osmotic form for controlled release of active principles |
| 11/05/2008 | EP1988162A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 11/05/2008 | EP1988108A1 Temperature and pH-sensitive block copolymer having having excellent gel strength, method of preparing the same, and drug delivery system using the same |
| 11/05/2008 | EP1987844A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 11/05/2008 | EP1987832A1 Sustained-release tablet composition of pramipexole |
| 11/05/2008 | EP1987830A1 Stabilized pharmaceutical composition |
| 11/05/2008 | EP1987825A1 Pharmaceutical composition comprising oseltamivir phosphate |
| 11/05/2008 | EP1987823A1 Condensation aerosol containing zaleplon for inhalation |
| 11/05/2008 | EP1987822A1 Skin patch |
| 11/05/2008 | EP1987821A2 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
| 11/05/2008 | EP1987820A1 Slow release misoprostol for obstetric and/or gynaecological applications |
| 11/05/2008 | EP1987819A1 Injectable presentation type of flupirtin |
| 11/05/2008 | EP1987817A2 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 11/05/2008 | EP1987816A1 Adsorbate of a rasagiline salt with a water-soluble inactive ingredient |
| 11/05/2008 | EP1987815A1 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders |
| 11/05/2008 | EP1987814A1 Mifepristone pharmaceutical compositions and their methods of preparation |
| 11/05/2008 | EP1987813A1 Injectable pharmaceutical formulation of taxoids in stable liposomes |
| 11/05/2008 | EP1987151A2 Lipoparticles comprising ion channels, methods of making, and using the same |
| 11/05/2008 | EP1987145A2 Rna interference mediated inhibition of hepatitis c virus |
| 11/05/2008 | EP1987082A1 Subtituted organopolysiloxanes and use thereof |
| 11/05/2008 | EP1987067A2 Antibody formulation |
| 11/05/2008 | EP1986952A2 Methods of treating cystic fibrosis |
| 11/05/2008 | EP1986709A1 Joining and/or sealing tissues through photo-activated cross-linking of matrix proteins |
| 11/05/2008 | EP1986704A1 Haemostatic agent |
| 11/05/2008 | EP1986693A1 A base forming drug-layered silicate hybrid containing basic polymer and its synthesis method |
| 11/05/2008 | EP1986692A2 Methods for regulating gelation of polysaccharide solutions and uses thereof |
| 11/05/2008 | EP1986679A2 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 11/05/2008 | EP1986659A2 Stable dosage formulations of imidazolylalkyl-pyridines |
| 11/05/2008 | EP1986650A1 Tamper resistant dosage forms |
| 11/05/2008 | EP1986642A1 Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 11/05/2008 | EP1986618A2 Adhesive preparation comprising sufentanil and methods of using the same |
| 11/05/2008 | EP1986617A2 Extraction, preparation and use of active principles of the aloe plant to realize of self-medication devices such as aloe controlled-release gauzes, bandages, stockings, elastic bands and arch supports |
| 11/05/2008 | EP1986616A2 Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol |
| 11/05/2008 | EP1986615A2 Capsules or microcapsules with stable outer hydrophilic layer for rapid buccal disintegration |
| 11/05/2008 | EP1986614A2 Protein hydrolysate excipients |
| 11/05/2008 | EP1986613A2 Microtablet-based pharmaceutical preparation |